Skip to main content

MoneyWorks4Me

Alembic Pharmaceuticals informs about press release

26 Oct 2020 Evaluate

Alembic Pharmaceuticals has informed the exchange that the Company has received US Food & Drug Administration (USFDA) Final Approval for Timolol Maleate Ophthalmic Gel Forming Solution, 0.25% and 0.5%. In this regard the company has enclosed its press release on 26th October 2020.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1778.25
Dr. Reddys Labs. 1350.20
Cipla 1380.00
Lupin 2009.00
Zydus Lifesciences 1244.00
View more..